Evidence map›Paper›PMID 25033211›Full record

ArticlePloS one2014

Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues.

Giulia Biffi, David Tannahill, Jodi Miller, William J Howat, Shankar Balasubramanian

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 222 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Light-Activated Molecules Targeting G-Quadruplex Nucleic Acids.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  18. Article
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Giulia BiffiCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
David TannahillCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Jodi MillerCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
William J HowatCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Shankar BalasubramanianCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom; Department of Chemistry, University of Cambridge, Cambridge, United Kingdom.
University of Cambridge · GBCancer Research UK Cambridge Center · GB

Funding

Cancer Research UK 11961Cancer Research UK 12488Cancer Research UK C9681/A11961
6 · The paper itself

Abstract

Four-stranded G-quadruplex DNA secondary structures have recently been visualized in the nuclei of human cultured cells. Here, we show that BG4, a G-quadruplex-specific antibody, can be used to stain DNA G-quadruplex structures in patient-derived tissues using immunohistochemistry. We observe a significantly elevated number of G-quadruplex-positive nuclei in human cancers of the liver and stomach as compared to background non-neoplastic tissue. Our results suggest that G-quadruplex formation can be detected and measured in patient-derived material and that elevated G-quadruplex formation may be a characteristic of some cancers.

Indexed as

Cell Line, TumorDNAGastric MucosaG-QuadruplexesHumansImmunohistochemistryLiverLiver NeoplasmsStomach NeoplasmsDNA

Identifiers

PMID25033211
PMCPMC4102534
OpenAlexW2100966371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.